Skip to content
ISMO

Research updates in kidney cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jack Gleeson, Haematology Specialist in Memorial Sloan...
Research updates in kidney cancer

Burned in the USA — the high risk of burnout for US oncologists

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer 2020 conference heard a keynote address from Dr...
Burned in the USA — the high risk of burnout for US oncologists

Body and mind combined in cancer care

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting heard from Dr Helen Greally, National Clinical Lead in Psycho-Oncology...
Body and mind combined in cancer care

Choosing the right treatment pathway in pancreatic cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference also heard a presentation from Prof Maeve Lowery, Consultant Medical...
Choosing the right treatment pathway in pancreatic cancer

Oncology community standing together, apart

Gathering Around Cancer, virtual meeting, 5-6 November 2020 This year’s Gathering Around Cancer 2020 conference was opened by Prof John...
Oncology community standing together, apart

Advances in lung cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jarushka Naidoo, Consultant Medical Oncologist at Beaumont...
Advances in lung cancer

Breast cancer care in the Covid context

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting also heard from Prof Seamus O’Reilly, National Director in Medical...
Breast cancer care in the Covid context

Chemotherapy and Covid-19 — assessing the outcomes

Gathering Around Cancer, virtual meeting, 5-6 November 2020 During the segment of Gathering Around Cancer 2020 dedicated to issues around...
Chemotherapy and Covid-19 — assessing the outcomes

Clinical perspectives on melanoma

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer conference also heard from Dr Fergal Kelleher, Consultant...
Clinical perspectives on melanoma

ASCO Annual Meeting 2019, Chicago, IL

Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society of Clinical Oncology (ASCO)...
ASCO Annual Meeting 2019, Chicago, IL
Research updates in kidney cancer Research updates in kidney cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jack Gleeson, Haematology Specialist in Memorial Sloan...
Burned in the USA — the high risk of burnout for US oncologists Burned in the USA — the high risk of burnout for US oncologists
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer 2020 conference heard a keynote address from Dr...
Body and mind combined in cancer care Body and mind combined in cancer care
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting heard from Dr Helen Greally, National Clinical Lead in Psycho-Oncology...
Choosing the right treatment pathway in pancreatic cancer Choosing the right treatment pathway in pancreatic cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference also heard a presentation from Prof Maeve Lowery, Consultant Medical...
Oncology community standing together, apart Oncology community standing together, apart
Gathering Around Cancer, virtual meeting, 5-6 November 2020 This year’s Gathering Around Cancer 2020 conference was opened by Prof John...
Advances in lung cancer Advances in lung cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jarushka Naidoo, Consultant Medical Oncologist at Beaumont...
Breast cancer care in the Covid context Breast cancer care in the Covid context
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting also heard from Prof Seamus O’Reilly, National Director in Medical...
Chemotherapy and Covid-19 — assessing the outcomes Chemotherapy and Covid-19 — assessing the outcomes
Gathering Around Cancer, virtual meeting, 5-6 November 2020 During the segment of Gathering Around Cancer 2020 dedicated to issues around...
Clinical perspectives on melanoma Clinical perspectives on melanoma
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer conference also heard from Dr Fergal Kelleher, Consultant...
ASCO Annual Meeting 2019, Chicago, IL ASCO Annual Meeting 2019, Chicago, IL
Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society of Clinical Oncology (ASCO)...

ISMO Travel Bursary Awards 2021

,

The ISMO meeting featured some of the best cancer research currently being undertaken in Ireland This year’s Irish Society of Medical Oncology (ISMO) annual meeting took place on Friday, 29 January 2021. As a result of Covid-19, the meeting was held virtually, streaming live from the Fintan Gunne Theatre, Catherine McAuley Centre, Mater Misericordiae University…

Update Journal- Oncology & Haematology

,

CPD Module- Cervical cancer

2 CPD Hours Authors Caitriona Duggan, Registered Advanced Nurse Practitioner, Oncology Department, Portiuncula Hospital, Ballinasloe, Co. Galway. This module outlines what ‘cervical’ is. It highlights the epidemiology, pathogenesis and risk factors of cervical cancer. The module summarises the staging and complex management options of the various stages that comprise cervical cancer. It also discusses cervical…

CPD Module- Multiple myeloma

1.5 CPD Hours Authors Ronan Desmond MD, MRCPI, FRCPath, Consultant Haematologist, Tallaght Hospital, Dublin 24 and Naas General Hospital, Co Kildare This module will begin with a case study and discuss further when to suspect the presence of myeloma and investigations to consider. I will also discuss indications to treat and the current treatment paradigm…

PARP inhibitors in cancer – shifting the paradigm to frontline treatment

,

The last decade has seen major advances in oncology therapy with the addition of PARP inhibitors, with significant updated data on their usage across a range of cancers in the last 12 months Tubo-ovarian cancer The last 12 months has continued to see PARP inhibitors lead the field as regards therapeutic advancement in advanced tubo-ovarian…

2019 European Society for Medical Oncology (ESMO) Asia Congress

,

First China-manufactured trastuzumab biosimilar HLX02 global phase 3 trial met primary endpoint in breast cancer outcomes The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomised phase 3 study reported at…

The Gander – 14 November 2019

,
Scroll To Top